Xinghualing Methadone Drug Point
Welcome,         Profile    Billing    Logout  
 5 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wang, Suping
NCT03962816: Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients

Not yet recruiting
4
300
RoW
20 µg recombinant hepatitis B vaccine at months 0, 1, and 6, 20 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6, 60 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6
Shanxi Medical University, Centers for Disease Control and Prevention, China
Hepatitis B Vaccine
02/20
12/23
NCT03962803: Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients

Not yet recruiting
4
300
RoW
20 µg recombinant hepatitis B vaccine at months 0, 1, and 6, 20 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6, 60 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6
Shanxi Medical University, Centers for Disease Control and Prevention, China
Hepatitis B Vaccine
02/20
12/23
NCT05099757: The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students

Not yet recruiting
4
150
NA
20 µg dose hepatitis B vaccine
Shanxi Medical University
Hepatitis B Vaccine
11/22
12/23
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）

Recruiting
3
1630
RoW
Alteplase, rt-PA, Tenecteplase, TNK-tPA
Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd
Acute Ischemic Stroke
11/23
03/24
Feng, Yongliang
NCT03962881: Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population

Not yet recruiting
4
300
RoW
20 µg recombinant hepatitis B vaccine at months 0, 1, and 6, 20 µg recombinant hepatitis B vaccine at months 0, 1, 2,and 6, 60 µg recombinant hepatitis B vaccine at months 0, 1, 2,and 6
Shanxi Medical University, Centers for Disease Control and Prevention, China
Hepatitis B Vaccine
02/20
12/23
NCT03962816: Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients

Not yet recruiting
4
300
RoW
20 µg recombinant hepatitis B vaccine at months 0, 1, and 6, 20 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6, 60 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6
Shanxi Medical University, Centers for Disease Control and Prevention, China
Hepatitis B Vaccine
02/20
12/23

Download Options